Company news
Shandong Weigao Blood Purification Products Co., Ltd. Class A (SSE:603014) news
Shandong Weigao Blood Purification Products Co., Ltd. Class A news releases on 6ix. Latest, Sep 25, 2026: "SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO.…
View Shandong Weigao Blood Purification Products Co., Ltd. Class A →
Press releases & updates
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Announcement on Results of Share Issuance for Asset Acquisition and Related Party Transaction and Changes in Share Capital
September 24, 2026
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Announcement on Completion of Transfer of Target Assets in Connection with the Issuance of Shares for Asset Acquisition and Related Party Transaction
September 14, 2026
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026
September 7, 2026
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Temporarily Idle Raised Funds
September 1, 2026
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Announcement on Obtaining the Registration Approval from the China Securities Regulatory Commission for the Issuance of Shares to Purchase Assets and Related Party Transactions
August 31, 2026
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
August 25, 2026
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Announcement on Explanation of Revisions to the Report on Issuance of Shares for Asset Acquisition and Related Party Transaction
August 12, 2026
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Announcement on Approval by Shanghai Stock Exchange M&A and Restructuring Review Committee of Share Issuance for Asset Acquisition and Related Party Transaction
August 10, 2026
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Announcement on Progress in Providing Guarantee for Joint Venture
August 7, 2026
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Announcement on Meeting Arrangement of the Shanghai Stock Exchange M&A and Restructuring Committee for the Review of the Company's Share Issuance for Asset Acquisition and Related Party Transaction
August 4, 2026
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Announcement on the Explanation of Revisions to the Report on Issuance of Shares for Asset Acquisition and Related Party Transaction and the Responses to the Review Inquiry Letter
August 3, 2026
"SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD."Announcement on Redemption at Maturity of Temporarily Idle Raised Funds for Cash Management
July 1, 2026
Announcement on Abnormal Fluctuations in Stock Trading
June 12, 2026
Announcement on Resolutions of the 24th Meeting of the 2nd Board of Directors
June 9, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
June 8, 2026
Announcement on Redemption at Maturity of Temporarily Idle Raised Funds for Cash Management
June 5, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 25, 2026
Announcement on Using Partial Temporarily Idle Raised Funds for Cash Management
May 22, 2026
Indicative Announcement on Reply to the Review Inquiry Letter Regarding the Application for the Issuance of Shares to Purchase Assets and the Related Party Transaction
May 21, 2026
Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction
May 13, 2026
Announcement on Listing and Circulation of Partial Restricted Shares from the Initial Public Offering and Strategically Placed Restricted Shares
May 11, 2026
Announcement on Resolutions of the 22nd Meeting of the 2nd Board of Directors
April 29, 2026
Announcement on Recognition of the National Manufacturing Single-Item Champion Enterprise
April 20, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
April 17, 2026
Announcement on Convening the 2025 Annual Performance Briefing
April 9, 2026
Special Report on Deposit, Management and Actual Use of Raised Funds
March 27, 2026
Announcement on Amendment to Report (Declaration) on Purchasing Assets through Issuance of Shares and Related Party Transaction
March 11, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
February 27, 2026
Announcement on the Self-Inspection Report on Insider Trading by Persons Aware of Material Non-public Information Related to the Issuance of Shares to Acquire Assets and Related Party Transactions
February 25, 2026
Notice on Convening the 1st Extraordinary General Meeting in 2026
February 11, 2026
Announcement on Progress in Share Issuance for Asset Acquisition and Related Party Transaction
January 28, 2026
Indicative Announcement on Changes in Shareholders' Equity
January 5, 2026
Announcement on Resolutions of the 19th Meeting of the 2nd Board of Directors
December 1, 2025
Announcement on Equal Capital Increase of the Joint Venture Company and Related Party Transactions
November 20, 2025
Announcement on Circulation of Restricted Stocks in Offline Placement of Initial Public Offering
November 12, 2025
Announcement on General Risk Warning Regarding Disclosure of the Proposed Transaction and Resumption of Trading of Shares
October 31, 2025
Announcement on Using Self-owned Idle Funds to Purchase Wealth Management Products
October 30, 2025
Announcement on Progress in Trading Suspension in Connection with Proposed Asset Acquisition through Share Issuance and Related Party Transactions
October 24, 2025
Announcement on Trading Suspension in Connection with Proposed Asset Acquisition through Share Issuance and Related Party Transactions
October 17, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
October 16, 2025
Announcement on Adjusting the Distribution Amount per Share in the 2025 Semi-annual Profit Distribution Plan
October 9, 2025
Announcement on the Results of Granting in the 2025 Restricted Stock Incentive Plan
September 30, 2025
Verification Opinions of Remuneration and Appraisal Committee of the Board of Directors on the List of Incentive Recipients Granted under 2025 Restricted Stock Incentive Plan (Grant Date)
September 16, 2025
Announcement on Departure of Company Director, Election of Employee Director, and Adjustment of Members of the Special Committees of the 2nd Board of Directors
September 15, 2025
Remuneration and Appraisal Committee's Verification Opinions and Publicity Description on the List of Incentive Objects in 2025 Restricted Stock Incentive Plan
September 8, 2025
Announcement on Change of Business Scope, Abolishment of Board of Supervisors, and Amendments to the "Articles of Association" and Relevant Systems
August 27, 2025
Announcement on Resolutions of the 9th Meeting of the 2nd Board of Supervisors
July 22, 2025
Announcement on Using Partial Raised Funds to Increase Capital in Wholly-owned Subsidiary
May 27, 2025